November 3, 2011
An agreement on the expansion of their collaboration has been announced by Bayer Animal Health GmbH and AgraQuest, Inc. Wednesday (Nov 2).
The agreement will also allow Bayer to become the exclusive distributor of AgraQuest's Bacillus subtilis QST 713 in selected countries for poultry applications.
The product that will be distributed under the agreement will be Baymix(Registered) Grobig(Registered) BS, a feed additive based on AgraQuest"s patented strain of Bacillus subtilis and co-branded with AgraQuest's trademark SYMPATIC(TradeMark). Baymix(Registered) Grobig(Registered) BS has already received registration in India, Korea and Thailand and is already marketed by Bayer Animal Health in these countries. It will be launched in other key markets throughout Asia and Latin America, with registrations currently in process in eight countries.
"Bayer is looking forward to a long-term relationship with AgraQuest which will contribute to further foster our target to complete our customers' needs," says Alexander Jahn, Head of Region Asia within Bayer HealthCare Animal Health. "We already started to partner successfully in selected countries like India for example, which is one of the fastest growing poultry markets in Asia. With our excellent distribution footprint across most of the growing markets, we will contribute to a continuous success of Baymix(Registered) Grobig(Registered), especially in those markets, where the importance of poultry is increasing."
"We are excited to expand our relationship with a company that is both technically astute and so well experienced in the animal health market," said Mike Miille, President and COO of AgraQuest. "By combining strengths of both Bayer and AgraQuest, we can deliver cost effective and consistently performing natural products to poultry producers."
Baymix(Registered) Grobig(Registered) BS is a product designed to be complementary to existing poultry health regimes, brings balance to microflora of the intestinal tract of poultry. The genetically distinct QST 713 strain enhances digestion and has been shown to protect birds from profit robbing diseases such as necrotic enteritis.
"By teaming with Bayer in these key poultry markets, we can deliver to producers a product that allows treated poultry to reach their full genetic potential and maximize their return on investment," said Joe Schmidt, Vice President at AgraQuest. "We look forward to working with the Bayer country teams on this exciting offering."